New Drug Seeks Receptors in Sarcoma Cells and Attacks Tumors in Animal Trials
CCIL members Dipanjan Pan and Lawrence Schook have developed a new drug candidate that targets a receptor inside sarcoma cancer cells. This new drug candidate shows promise at shrinking tumors and making cancer cells less likely to multiply, reducing their ability to spread to other tissues. Learn more.
|Graduate student Fatemeh Ostadhossein and Bioengineering Professor Dipanjan Pan.|
Lu Named to the Clarivate Analytics Highly Cited Researchers List
Chemistry Professor Yi Lu, a CCIL member, is one of 11 Illinois faculty members named to the 2018 Clarivate Analytics Highly Cited Researchers list. This list recognizes “leading researchers in the sciences and social sciences from around the world,” according to Clarivate Analytics.
Lu is the Jay and Ann Schenck Professor of Chemistry at Illinois and is a Fellow of the American Association for the Advancement of Science, a Fellow of the Royal Society of Chemistry, and a recipient of a Howard Hughes Medical Institute Professors Award. He has appeared on the Highly Cited Researchers list every year since 2015. Learn more.
Cancer Center at Illinois Seed Funding Call for Proposals
The CCIL Seed Funding program provides support for Illinois cancer research teams, with the expected outcome of a fundable interdisciplinary research proposal. The CCIL anticipates funding two or three interdisciplinary research proposals during the 2018-2019 cycle. Learn more about eligibility and deadlines here.
|SAVE THE DATE: JANUARY FACULTY SEMINAR SERIES
January Faculty Seminar Series
Save the date for January's Faculty Seminar Series on January 24, 2019, from 3:00 to 4:00 p.m. at Beckman Institute (Room 4269) featuring Emad Tajkhorshid, professor of biochemistry, and Paul Selvin, professor of physics.
| EXTERNAL FUNDING OPPORTUNITIES